Story thread · 2 reports / 1 sources
Mirum to present phase 3 hepatitis delta study results Monday
investing.com · 4h
First report: Kodiak Sciences to report phase 3 trial results Monday — investing.com, 2d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.